CS logo
small CS logo
Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University

Philadelphia, Pennsylvania, United States
Ophthalmology clinic in Philadelphia, Pennsylvania
840 Walnut St # 930, Philadelphia, PA 19107

About Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
GenSight Biologics
2
Total Rows: 1

Clinical Trials at Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University


During the past decade, Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200Started TrialsCompleted Trails20160123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
2016-02-23
2019-07-04
Completed
39
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)
2016-01-01
2018-12-01
Completed
37

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsGenSight Biologics: 2GenSight Biologics: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University


According to Clinical.Site data, the most researched conditions in "Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University" are "Optic, Atrophy, Hereditary, Leber" (2 trials). Many other conditions were trialed in "Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University" in a lesser frequency.

Clinical Trials Intervention Types at Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University


Most popular intervention types in "Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University" are "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "GS010" (2 trials) and "Sham Intravitreal Injection" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University


The vast majority of trials in "Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University" are 2 trials for "All" genders.

Clinical Trials Status at Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University


Currently, there are NaN active trials in "Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2